Venus Medtech (Hangzhou) Inc. announced Poll Results of the 2023 Fourth Extraordinary General Meeting approved To elect Mr. Liqiao Ma as an executive director of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 HKD | -0.71% | -.--% | -.--% |
04-01 | Venus Medtech Trims Loss in 2023 as Revenue Grows Nearly 21% | MT |
03-28 | Venus Medtech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 315M | |
+9.96% | 125B | |
-7.38% | 10.97B | |
+2.70% | 8.99B | |
-19.67% | 4.86B | |
+34.49% | 5.38B | |
+8.18% | 3.43B | |
-9.55% | 2.78B | |
-5.57% | 2.22B | |
-0.60% | 2.21B |
- Stock Market
- Equities
- 2500 Stock
- News Venus Medtech (Hangzhou) Inc.
- Venus Medtech Inc. Approves Mr. Liqiao Ma as an Executive Director